The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Multidrug resistance: Physiological principles and nanomedical solutions
Open accessAbstract
Multidrug (MDR) resistance is a pathophysiological phenomenon employed by cancer cells which limits the prolonged and effective use of chemotherapeutic agents. MDR is primarily based on the over-expression of drug efflux pumps in the cellular membrane. Prominent examples of such efflux pumps, which belong to the ATP-binding cassette (ABC) superfamily of proteins, are Pgp (P-glycoprotein) and MRP (multidrug resistance-associated protein), nowadays officially known as ABCB1 and ABCC1. Over the years, several strategies have been evaluated to overcome MDR, based not only on the use of low-molecular-weight MDR modulators, but also on the implementation of 1-100(0) nm-sized drug delivery systems. In the present manuscript, after introducing the most important physiological principles of MDR, we summarize prototypic nanomedical strategies to overcome multidrug resistance, including the use of carrier materials with intrinsic anti-MDR properties, the use of nanomedicines to modify the mode of cellular uptake, and the co-formulation of chemotherapeutic drugs together with low- and high-molecular-weight MDR inhibitors within a single drug delivery system. While certain challenges still need to be overcome before such constructs and concepts can be widely applied in the clinic, the insights obtained and the progress made strongly suggest that nanomedicine formulations hold significant potential for improving the treatment of multidrug-resistant malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
Juliano, R. L., & Ling, V. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90160-7 · Cited by 3,296
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
Schinkel, A. H., Smit, J. J. M., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., te Riele, H. P. J., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90212-7 · Cited by 2,281
Zhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A.-M., Sampath, J., Morris, J. J., Lagutina, I., Grosveld, G. C., Osawa, M., Nakauchi, H., et al. (2001) · Nature Medicine · doi:10.1038/nm0901-1028 · Cited by 2,280 · cited 2×
“ABCG2 is furthermore highly expressed in stem cells of different organs, being responsible for a socalled ‘side-population phenotype’, which is marked by a reduced uptake of Hoechst 33342 [40].”
BackgroundSahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.036 · Cited by 2,181
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
The human ATP-binding cassette (ABC) transporter superfamily
Dean, M., Hamon, Y., & Chimini, G. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31588-1 · Cited by 1,302
Batrakova, E. V., & Kabanov, A. V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.013 · Cited by 1,278
Hyde, S. C., Emsley, P., Hartshorn, M. J., Mimmack, M. M., Gileadi, U., Pearce, S. R., Gallagher, M. P., Gill, D. R., Hubbard, R. E., & Higgins, C. F. (1990) · Nature · doi:10.1038/346362a0 · Cited by 1,145
Maliepaard, M., Scheffer, G. L., Faneyte, I. F., van Gastelen, M. A., Pijnenborg, A. C. L. M., Schinkel, A. H., van de Vijver, M. J., Scheper, R. J., & Schellens, J. H. M. (2001) · PubMed · Cited by 1,130
The Human ATP-Binding Cassette (ABC) Transporter Superfamily
Dean, M. (2001) · Genome Research · doi:10.1101/gr.gr-1649r · Cited by 1,113
Schinkel, A. H., Mayer, U., Wagenaar, E., Mol, C. A. A. M., van Deemter, L., Smit, J. J. M., van der Valk, M. A., Voordouw, A. C., Spits, H., van Tellingen, O., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4028 · Cited by 937
Leier, I., Jedlitschky, G., Buchholz, U., Cole, S. P., Deeley, R. G., & Keppler, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46856-1 · Cited by 853
Jonker, J. W., Buitelaar, M., Wagenaar, E., van der Valk, M. A., Scheffer, G. L., Scheper, R. J., Plösch, T., Kuipers, F., Elferink, R. P. J. O., Rosing, H., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202607599 · Cited by 822
Macromolecular therapeutics in cancer treatment: The EPR effect and beyond
Maeda, H. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.038 · Cited by 814
Scharenberg, C. W., Harkey, M. A., & Torok-Storb, B. (2002) · Blood · doi:10.1182/blood.v99.2.507 · Cited by 770
Reduced permeability in CHO cells as a mechanism of resistance to colchicine
Ling, V., & Thompson, L. H. (1974) · Journal of Cellular Physiology · doi:10.1002/jcp.1040830114 · Cited by 686
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.
Zaman, G. J., Flens, M. J., van Leusden, M. R., de Haas, M., Mülder, H. S., Lankelma, J., Pinedo, H. M., Scheper, R. J., Baas, F., & Broxterman, H. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8822 · Cited by 680
Active transport of imatinib into and out of cells: implications for drug resistance
Thomas, J., Wang, L., Clark, R. E., & Pirmohamed, M. (2004) · Blood · doi:10.1182/blood-2003-12-4276 · Cited by 643
Pluronic® block copolymers for overcoming drug resistance in cancer
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00047-9 · Cited by 636
BindingDB (2013) · PubMed · doi:10.7270/q2q81fck · Cited by 571
Tumour-targeted nanomedicines: principles and practice
Lammers, T., Hennink, W. E., & Storm, G. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604483 · Cited by 542
Self-citationThe P-glycoprotein multidrug transporter
Sharom, F. J. (2011) · Essays in Biochemistry · doi:10.1042/bse0500161 · Cited by 509
Fluorescent cellular indicators are extruded by the multidrug resistance protein.
Homolya, L., Holló, Z., Germann, U. A., Pastan, I., Gottesman, M. M., & Sarkadi, B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80566-3 · Cited by 495
ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells.
Horio, M., Gottesman, M. M., & Pastan, I. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.10.3580 · Cited by 476
Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
Chang, A. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2010.08.022 · Cited by 443
Wijnholds, J., Evers, R., van Leusden, M. R., Mol, C. A. A. M., Zaman, G. J. R., Mayer, U., Beijnen, J. H., Valk, M. V. D., Krimpenfort, P., & Borst, P. (1997) · Nature Medicine · doi:10.1038/nm1197-1275 · Cited by 432
ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein.
Jedlitschky, G., Leier, I., Buchholz, U., M Center, & KEPPLER, D. O. R. (1994) · PubMed · Cited by 426
Burger, H., van Tol, H., Boersma, A. W. M., Brok, M., Wiemer, E. A. C., Stoter, G., & Nooter, K. (2004) · Blood · doi:10.1182/blood-2004-04-1398 · Cited by 417
Xiong, X.-B., & Lavasanifar, A. (2011) · ACS Nano · doi:10.1021/nn2013707 · Cited by 411
Co-Delivery of siRNA and An Anticancer Drug for Treatment of Multidrug-Resistant Cancer
Saad, M., Garbuzenko, O. B., & Minko, T. (2008) · Nanomedicine · doi:10.2217/17435889.3.6.761 · Cited by 367
Expression of members of the multidrug resistance protein family in human term placenta
St-Pierre, M. V., Serrano, M. A., Macias, R. I. R., Dubs, U., Hoechli, M., Lauper, U., Meier, P. J., & Marin, J. J. G. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.4.r1495 · Cited by 325
Patil, Y., Sadhukha, T., Ma, L., & Panyam, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.01.021 · Cited by 317
Chen, Z., Robey, R. W., Belinsky, M. G., Shchaveleva, I., Ren, X. Q., Sugimoto, Y., Ross, D. D., Bates, S. E., & Kruh, G. D. (2003) · PubMed · Cited by 305
JEDLITSCHKY, G., LEIER, I., BUCHHOLZ, U., HUMMEL-EISENBEISS, J., BURCHELL, B., & KEPPLER, D. (1997) · Biochemical Journal · doi:10.1042/bj3270305 · Cited by 303
LEIER, I., JEDLITSCHKY, G., BUCHHOLZ, U., CENTER, M., COLE, S. P. C., DEELEY, R. G., & KEPPLER, D. (1996) · Biochemical Journal · doi:10.1042/bj3140433 · Cited by 291
Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro
Kievit, F. M., Wang, F. Y., Fang, C., Mok, H., Wang, K., Silber, J. R., Ellenbogen, R. G., & Zhang, M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.024 · Cited by 289
Emilienne Soma, C., Dubernet, C., Bentolila, D., Benita, S., & Couvreur, P. (2000) · Biomaterials · doi:10.1016/s0142-9612(99)00125-8 · Cited by 281
Nanomedicine in the diagnosis and therapy of neurodegenerative disorders
Kabanov, A. V., & Gendelman, H. E. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.014 · Cited by 277
Brangi, M., Litman, T., Ciotti, M., Nishiyama, K., Kohlhagen, G., Takimoto, C. H. M., Robey, R. W., Pommier, Y. G., Fojo, T., & Bates, S. E. (1999) · PubMed · Cited by 263
Evers, R., Zaman, G. J., van Deemter, L., Jansen, H., Calafat, J., Oomen, L. C., Oude Elferink, R. P., Borst, P., & Schinkel, A. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118535 · Cited by 260
Renes, J., De Vries, E. G. E., Nienhuis, E. F., Jansen, P. L. M., & Müller, M. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702360 · Cited by 256
Zeng, H., Chen, Z., Belinsky, M. G., Rea, P. A., & Kruh, G. D. (2001) · PubMed · Cited by 255
Batrakova, E. V., Li, S., Elmquist, W. F., Miller, D. W., Alakhov, V. Y., & Kabanov, A. V. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2165 · Cited by 229
Drach, J., Gsur, A., Hamilton, G., Zhao, S., Angerler, J., Fiegl, M., Zojer, N., Raderer, M., Haberl, I., Andreeff, M., et al. (1996) · Blood · doi:10.1182/blood.v88.5.1747.1747 · Cited by 224
Chen, Y. N., Mickley, L. A., Schwartz, A. M., Acton, E. M., Hwang, J. L., & Fojo, A. T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38781-2 · Cited by 221
The power of the pump: Mechanisms of action of P-glycoprotein (ABCB1)
Ambudkar, S. V., Kim, I.-W., & Sauna, Z. E. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.10.010 · Cited by 217
Wu, J. H., Lu, Y., Lee, A., Pan, X., Yang, X., Zhao, X. B., & Lee, R. J. (2007) · PubMed · Cited by 216
Membrane Topology and Glycosylation of the Human Multidrug Resistance-associated Protein
Bakos, É., Hegedüs, T., Holló, Z., Welker, E., Tusnády, G. E., Zaman, G. J. R., Flens, M. J., Váradi, A., & Sarkadi, B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.21.12322 · Cited by 211
Song, X. R., Cai, Z., Zheng, Y., He, G., Cui, F. Y., Gong, D. Q., Hou, S. X., Xiong, S. J., Lei, X. J., & Wei, Y. Q. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.02.018 · Cited by 211
Wong, H. L., Bendayan, R., Rauth, A. M., & Wu, X. Y. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.09.007 · Cited by 207
Localization of the ABCG2 mitoxantrone resistance-associated protein in normal tissues
Fetsch, P. A., Abati, A., Litman, T., Morisaki, K., Honjo, Y., Mittal, K., & Bates, S. E. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.04.024 · Cited by 197
Transport properties of the multidrug resistance‐associated protein (MRP) in human tumour cells
Holló, Z., Homolya, L., Hegedüs, T., & Sarkadi, B. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00237-2 · Cited by 195
Aronica, E., Gorter, J. A., Redeker, S., Van Vliet, E. A., Ramkema, M., Scheffer, G. L., Scheper, R. J., Van Der Valk, P., Leenstra, S., Baayen, J. C., et al. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.66604.x · Cited by 187
Hamada, H., & TSURUO, T. (1988) · PubMed · Cited by 176
Patel, N. R., Rathi, A., Mongayt, D., & Torchilin, V. P. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.082 · Cited by 173
Bart, J., Hollema, H., Groen, H. J. M., de Vries, E. G. E., Hendrikse, N. H., Sleijfer, D. T., Wegman, T. D., Vaalburg, W., & van der Graaf, W. T. A. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.05.010 · Cited by 164
Zhou, S., Zong, Y., Ney, P. A., Nair, G., Stewart, C. F., & Sorrentino, B. P. (2005) · Blood · doi:10.1182/blood-2004-04-1566 · Cited by 157
Du, J., Lü, W.-L., Ying, X., Liu, Y., Du, P., Tian, W. J., Men, Y., Guo, J., Zhang, Y., Li, R., et al. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800218q · Cited by 157
Raggers, R. J., van Helvoort, A., Evers, R., & Gerrit van, M. E. E. R. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.3.415 · Cited by 155
Slovak, M. L., Hoeltge, G. A., Dalton, W. S., & Trent, J. M. (1988) · PubMed · Cited by 153
Purification and 3D Structural Analysis of Oligomeric Human Multidrug Transporter ABCG2
McDevitt, C. A., Collins, R. F., Conway, M. A., Modok, S., Storm, J., Kerr, I. D., Ford, R. C., & Callaghan, R. (2006) · Structure · doi:10.1016/j.str.2006.08.014 · Cited by 132
Wils, P., Phung-Ba, V., Warnery, A., Lechardeur, D., Raeissi, S. D., Hidalgo, I. J., & Scherman, D. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90580-0 · Cited by 131
Saison, C., Helias, V., Ballif, B. A., Peyrard, T., Puy, H., Miyazaki, T., Perrot, S., Vayssier‐Taussat, M., Waldner, M., Pennec, P. L., et al. (2012) · Nature Genetics · doi:10.1038/ng.1070 · Cited by 126
Volk, E. L., Rohde, K., Rhee, M., McGuire, J. J., Doyle, L. A., Ross, D. D., & Schneider, E. (2000) · PubMed · Cited by 125
Köck, K., Grube, M., Jedlitschky, G., Oevermann, L., Siegmund, W., Ritter, C. A., & Kroemer, H. K. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746060-00001 · Cited by 119
Antiestrogens and steroid hormones: Substrates of the human P-glycoprotein
Rao, U. S., Fine, R. L., & Scarborough, G. A. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90099-x · Cited by 116
Eytan, G. D., Regev, R., Oren, G., Hurwitz, C. D., & Assaraf, Y. G. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00104.x · Cited by 115
Dekkers, D. W. C., Comfurius, P., Schroit, A. J., Bevers, E. M., & Zwaal, R. F. A. (1998) · Biochemistry · doi:10.1021/bi981011w · Cited by 113
Sugawara, I., Akiyama, S., Scheper, R. J., & Itoyama, S. (1997) · Cancer Letters · doi:10.1016/s0304-3835(96)04542-9 · Cited by 111
Bellamy, W. T., Dalton, W. S., Kailey, J. M., Gleason-Guzman, M. C., McCloskey, T. M., Dorr, R. T., & Alberts, D. S. (1988) · PubMed · Cited by 103
Nakayama, A., Matsuo, H., Takada, T., Ichida, K., Nakamura, T., Ikebuchi, Y., Ito, K., Hosoya, T., Kanai, Y., Suzuki, H., et al. (2011) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2011.633953 · Cited by 102
Spiegl‐Kreinecker, S., Buchroithner, J., Elbling, L., Steiner, E., Wurm, G., Bodenteich, A., Fischer, J., Micksche, M., & Berger, W. (2002) · Journal of Neuro-Oncology · doi:10.1023/a:1015735815111 · Cited by 99
Sugiyama, Y., Kato, Y., & Chu, X. (1998) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051078 · Cited by 95
Multidrug-resistance phenotype of a subpopulation of T-lymphocytes without drug selection
Neyfakh, A. A., Serpinskaya, A. S., Chervonsky, A. V., Apasov, S. G., & Kazarov, A. R. (1989) · Experimental Cell Research · doi:10.1016/0014-4827(89)90318-2 · Cited by 94
Export pumps for anionic conjugates encoded by MRP genes
KEPPLER, D. O. R., Cui, Y., König, J., Leier, I., & Nies, A. T. (1999) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(98)00015-6 · Cited by 93
Barnouin, K., Leier, I., Jedlitschky, G., Pourtier, A., König, J., Lehmann, W., & KEPPLER, D. O. R. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.34 · Cited by 91
Nieto-Montesinos, R., Béduneau, A., Pellequer, Y., & Lamprecht, A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.034 · Cited by 90
Pułaski, Ł., Jedlitschky, G., Leier, I., Buchholz, U., & KEPPLER, D. O. R. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00644.x · Cited by 82
Icreased drug permeability in Chinese hamster ovary cells in the presence of cyanide
See, Y. P., Carlsen, S. A., Till, J. E., & Ling, V. W. T. (1974) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(74)90148-5 · Cited by 81
Robillard, K. R., Hoque, M. T., & Bendayan, R. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.186916 · Cited by 79
Song, X. R., Zheng, Y., Zheng, Y., et al. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22200 · Cited by 75
P-glycoprotein inhibition by membrane cholesterol modulation
Fenyvesi, F., Fenyvesi, É., Szente, L., Goda, K., Bacsó, Z., Bácskay, I., Váradi, J., Kiss, T., Molnar, E. M., Janáky, T., et al. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.04.005 · Cited by 74
Fernández, S. B. M., Holló, Z., Kern, A., Bakos, É., Fischer, P. A., Borst, P., & Evers, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204267200 · Cited by 74
Wang, J.-C., Goh, B. C., Lü, W.-L., Zhang, Q., Chang, A., Liu, X. Y., Tan, T. M. C., & Lee, H.-S. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.822 · Cited by 70
Chen, Y., Zhang, W., Gu, J., Ren, Q., Fan, Z., Zhong, W., Fang, X., & Sha, X. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.015 · Cited by 66
Overcoming cellular multidrug resistance using classical nanomedicine formulations
Kunjachan, S., Błauż, A., Möckel, D., Theek, B., Kiessling, F. M., Etrych, T., Ulbrich, K., van Bloois, L., Storm, G., Bartosz, G., et al. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.08.028 · Cited by 64
Self-citationMignogna, C., Staibano, S., Altieri, V. M., Rosa, G. D., Pannone, G., Santoro, A., Zamparese, R., D'Armiento, M., Rocchetti, R., Mezza, E., et al. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-293 · Cited by 52
Scoazec, J., Bringuier, A. F., Medina, J. F., Martínez‐Ansó, E., Veissière, D., Feldmann, G., & Housset, C. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80419-9 · Cited by 52
Shen, H., Lee, F. Y., & Gan, J. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.175604 · Cited by 41
Draper, M. P., Martell, R. L., & Levy, S. B. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.0219a.x · Cited by 40
Nanotools for Megaproblems: Probing Protein Misfolding Diseases Using NanomedicineModusOperandi
Uversky, V. N., Kabanov, A. V., & Lyubchenko, Y. L. (2006) · Journal of Proteome Research · doi:10.1021/pr0603349 · Cited by 28
Syberg, F., Suveyzdis, Y., Kötting, C., Gerwert, K. B., & Hofmann, E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.359208 · Cited by 26
Sjölinder, M., Tornhamre, S., Claesson, H., Hydman, J., & LINDGREN, J. Å. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32448-2 · Cited by 26
Abulrob, A., & Gumbleton, M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1120 · Cited by 23
Ito, K., Weigl, K. E., Deeley, R. G., & Cole, S. P. C. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(03)00228-1 · Cited by 21
Expression of ATP-binding cassette transporter in human salivary ducts
Uematsu, T., Yamaoka, M., Doto, R., et al. (2003) · Archives of Oral Biology · doi:10.1016/s0003-9969(02)00159-0 · Cited by 21
Function of MRP1/ABCC1 is not dependent on cholesterol or cholesterol-stabilized lipid rafts
Meszaros, P., Klappe, K., Hummel, I., Hoekstra, D., & Kok, J. (2011) · Biochemical Journal · doi:10.1042/bj20110427 · Cited by 19
MRP1-Transfected Cells do not Show Increased Resistance Against Oxidative Stress
Balcerczyk, A., Rychlik, B., Kruszewski, M. K., Burchell, B., & Bartosz, G. (2003) · Free Radical Research · doi:10.1080/1071576021000040989 · Cited by 11
Self-citation
Cited by
Chen, Z., Shi, T., Zhang, L., Zhu, P., Deng, M., Huang, C., Hu, T., Jiang, L., & Li, J. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.10.010 · Cited by 729
Multidrug Resistance: An Emerging Crisis
Tanwar, J., Das, S., Fatima, Z., & Hameed, S. (2014) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2014/541340 · Cited by 657
Formulation of Poloxamers for Drug Delivery
Bodratti, A., & Alexandridis, P. (2018) · Journal of Functional Biomaterials · doi:10.3390/jfb9010011 · Cited by 589
Drug self-delivery systems for cancer therapy
Qin, S.-Y., Zhang, A.-Q., Cheng, S.-X., Rong, L., & Zhang, X.-Z. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.016 · Cited by 532
Lysosomes as mediators of drug resistance in cancer
Zhitomirsky, B., & Assaraf, Y. G. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2015.11.004 · Cited by 482
Metadata
- Authors
- Kunjachan, S., Rychlik, B., Storm, G., Kiessling, F., & Lammers, T.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 65
- Issue
- 13-14
- Pages
- 1852-1865
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W1985498995
- Cited by
- 259
- References
- 103
- FWCI
- 2.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.